• Something wrong with this record ?

Effect Of An Extra-Virgin Olive Oil Intake On The Delay Of Cognitive Decline: Role Of Secoiridoid Oleuropein?

B. Klimova, M. Novotný, K. Kuca, M. Valis,

. 2019 ; 15 (-) : 3033-3040. [pub] 20191029

Language English Country New Zealand

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc19044013

Currently, there is an increase in the number of the world's aging population. This aging process is often connected with cognitive decline of some functions such as memory or speed processing loss. Since Alzheimer's disease cannot be cured yet, considerable efforts are being made to at least delay this cognitive decline among elderly in order to maintain and prolong the quality of their life. This can also be achieved by non-pharmacological approaches such as performing physical activities, cognitive training, or adhering to a Mediterranean Diet (MedDiet). One of the components of MedDiet - extra-virgin olive oil (EVOO) - has considerable health benefits. The purpose of this review is to examine the effect of EVOO intake on the delay of cognitive decline among the elderly. The methodology is based on a literature review of available sources found on the research topic in three acknowledged databases: Web of Science, Scopus, and PubMed. The results of in vitro and in vivo studies indicate that the regular intake of EVOO is associated with enhanced cognitive functions, which means that this oil may have a neuroprotective effect and could positively prevent the development of dementia, especially Alzheimer's dementia. It is believed that secoiridoid oleuropein is responsible for this effectiveness. Furthermore, there is also a need of more randomized controlled studies or longitudinal observational studies to be performed to confirm the efficacy of the beneficial health effect of EVOO on the delay of cognitive decline.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044013
003      
CZ-PrNML
005      
20200109095226.0
007      
ta
008      
200107s2019 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/NDT.S218238 $2 doi
035    __
$a (PubMed)31754302
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Klimova, Blanka $u Department of Applied Linguistics, University of Hradec Kralove, Hradec Kralove 500 03, Czech Republic.
245    10
$a Effect Of An Extra-Virgin Olive Oil Intake On The Delay Of Cognitive Decline: Role Of Secoiridoid Oleuropein? / $c B. Klimova, M. Novotný, K. Kuca, M. Valis,
520    9_
$a Currently, there is an increase in the number of the world's aging population. This aging process is often connected with cognitive decline of some functions such as memory or speed processing loss. Since Alzheimer's disease cannot be cured yet, considerable efforts are being made to at least delay this cognitive decline among elderly in order to maintain and prolong the quality of their life. This can also be achieved by non-pharmacological approaches such as performing physical activities, cognitive training, or adhering to a Mediterranean Diet (MedDiet). One of the components of MedDiet - extra-virgin olive oil (EVOO) - has considerable health benefits. The purpose of this review is to examine the effect of EVOO intake on the delay of cognitive decline among the elderly. The methodology is based on a literature review of available sources found on the research topic in three acknowledged databases: Web of Science, Scopus, and PubMed. The results of in vitro and in vivo studies indicate that the regular intake of EVOO is associated with enhanced cognitive functions, which means that this oil may have a neuroprotective effect and could positively prevent the development of dementia, especially Alzheimer's dementia. It is believed that secoiridoid oleuropein is responsible for this effectiveness. Furthermore, there is also a need of more randomized controlled studies or longitudinal observational studies to be performed to confirm the efficacy of the beneficial health effect of EVOO on the delay of cognitive decline.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Novotný, Michal $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Kuca, Kamil $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic. Malaysia Japan International Institute of Technology (MJIIT), Universiti Teknologi Malaysia Kuala Lumpur, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysi.
700    1_
$a Valis, Martin $u Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove 500 05, Czech Republic.
773    0_
$w MED00183034 $t Neuropsychiatric disease and treatment $x 1176-6328 $g Roč. 15, č. - (2019), s. 3033-3040
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31754302 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200107 $b ABA008
991    __
$a 20200109095555 $b ABA008
999    __
$a ind $b bmc $g 1480602 $s 1082683
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 15 $c - $d 3033-3040 $e 20191029 $i 1176-6328 $m Neuropsychiatric disease and treatment $n Neuropsychiatr Dis Treat $x MED00183034
LZP    __
$a Pubmed-20200107

Find record

Citation metrics

Archiving options